OnabotulinumtoxinA (Botox) is FDA-approved for chronic migraine prevention and covered by most insurance plans as a medically necessary treatment — completely separate from cosmetic Botox. In-person at our Las Vegas, NV office.
📅 Schedule a ConsultationThe PREEMPT clinical trials established the FDA-approved protocol and demonstrated consistent, significant reductions in migraine days.
The PREEMPT protocol is the FDA-approved injection pattern for onabotulinumtoxinA (Botox) in chronic migraine prevention. It is entirely separate from cosmetic Botox and is covered by insurance as a medical treatment for qualifying patients.
Chronic migraine is defined as 15 or more headache days per month, with at least 8 meeting migraine criteria. For patients who meet this threshold and haven't responded adequately to oral preventives, Botox PREEMPT is the standard of care.
At Family1st, Botox PREEMPT is offered as part of our integrated neuropsychiatric care model. Chronic migraine and mental health conditions — particularly depression, anxiety, and PTSD — frequently co-occur and benefit from coordinated treatment.
Insurance requires specific clinical criteria. Your consultation confirms eligibility before scheduling treatment.
15 or more headache days per month, at least 8 meeting migraine criteria, documented over at least 3 months.
Most insurers require documented trial and failure of 2–3 oral preventives: topiramate, amitriptyline, propranolol, or valproate.
FDA approval is for adults 18 and older. Not currently approved for pediatric migraine under the PREEMPT protocol.
Contraindications include botulinum toxin allergy, active infection at injection sites, certain neuromuscular disorders, or pregnancy. Assessed at intake.
The FDA-approved PREEMPT protocol involves 155 units of onabotulinumtoxinA across 31 fixed injection sites in 7 specific head and neck muscle groups.